Literature DB >> 14527239

Advertising and prescription drugs: promotion, education, and the public's health.

Jerry Avorn1.   

Abstract

The data presented by Joel Weissman and colleagues and by Robert Dubois do not justify the conclusions that the effects of pharmaceutical promotion are beneficial. Among consumers of direct-to-consumer advertising (Weissman and colleagues), those heavily influenced by such promotion were no more likely than others were to have new conditions diagnosed or confirmed and were much less likely to have laboratory studies ordered or lifestyle changes recommended. A second study (Dubois) arguing that drug advertising improves the appropriateness of prescribing relies on unconvincing ecological arguments. A greater presence of noncommercial, public health-oriented communication would make a more useful and cost-effective impact on the nation's health.

Mesh:

Year:  2003        PMID: 14527239     DOI: 10.1377/hlthaff.w3.104

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  3 in total

Review 1.  Direct-to-consumer advertising of pharmaceuticals: developed countries experiences and Turkey.

Authors:  Semih Semin; Sahbal Aras; Dilek Guldal
Journal:  Health Expect       Date:  2007-03       Impact factor: 3.377

2.  Potential spillover educational effects of cancer-related direct-to-consumer advertising on cancer patients' increased information seeking behaviors: results from a cohort study.

Authors:  Andy S L Tan
Journal:  J Cancer Educ       Date:  2014-06       Impact factor: 2.037

Review 3.  Mapping conflict of interests: scoping review.

Authors:  Susan Chimonas; Maha Mamoor; Sophia A Zimbalist; Brooke Barrow; Peter B Bach; Deborah Korenstein
Journal:  BMJ       Date:  2021-11-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.